Skip to Content

Belatacept Injection

Last Updated: January 3, 2018
Status: Current

Belatacept Injection

Products Affected - Description
  • Nulojix lyophilized powder for solution for injection, Bristol-Myers Squibb
    250 mg, vial, 1 count (NDC 00003-0371-13)

Reason for the Shortage
  • Bristol-Myers Squibb has Nulojix in short supply due to manufacturing delays.

Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

  • Bristol-Myers Squibb has limited the distribution of Nulojix. They have product only for existing patients available through the US Nulojix Distribution Program. They have no estimated recovery date, but do not expect full recovery before the end of 2018. Nulojix is distributed by McKesson Plasma Biologics.


January 3, 2018; November 13, September 20, June 6, March 7, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.